BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 26114640)

  • 1. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
    Young Kim H; Young Yum S; Jang G; Ahn DR
    Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake.
    Verdurmen WP; Thanos M; Ruttekolk IR; Gulbins E; Brock R
    J Control Release; 2010 Oct; 147(2):171-9. PubMed ID: 20620184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
    Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
    Brooks N; Esparon S; Pouniotis D; Pietersz GA
    Molecules; 2015 Aug; 20(8):14033-50. PubMed ID: 26247926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
    Jobin ML; Alves ID
    Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating and cargo-delivery ability of a spider toxin-derived peptide in mammalian cells.
    Ponnappan N; Chugh A
    Eur J Pharm Biopharm; 2017 May; 114():145-153. PubMed ID: 28159722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP.
    Eggimann GA; Buschor S; Darbre T; Reymond JL
    Org Biomol Chem; 2013 Oct; 11(39):6717-33. PubMed ID: 23933745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides.
    Jobin ML; Blanchet M; Henry S; Chaignepain S; Manigand C; Castano S; Lecomte S; Burlina F; Sagan S; Alves ID
    Biochim Biophys Acta; 2015 Feb; 1848(2):593-602. PubMed ID: 25445669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell penetrating peptides: A concise review with emphasis on biomedical applications.
    Derakhshankhah H; Jafari S
    Biomed Pharmacother; 2018 Dec; 108():1090-1096. PubMed ID: 30372809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptide exploited syndecans.
    Letoha T; Keller-Pintér A; Kusz E; Kolozsi C; Bozsó Z; Tóth G; Vizler C; Oláh Z; Szilák L
    Biochim Biophys Acta; 2010 Dec; 1798(12):2258-65. PubMed ID: 20138023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
    Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
    Elife; 2021 Oct; 10():. PubMed ID: 34713805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenge to overcome current limitations of cell-penetrating peptides.
    Kim GC; Cheon DH; Lee Y
    Biochim Biophys Acta Proteins Proteom; 2021 Apr; 1869(4):140604. PubMed ID: 33453413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
    Futaki S; Nakase I
    Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the biomedical promise of cell penetrating peptides: limits versus prospects.
    Foerg C; Merkle HP
    J Pharm Sci; 2008 Jan; 97(1):144-62. PubMed ID: 17763452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell penetrating peptides: the potent multi-cargo intracellular carriers.
    Kardani K; Milani A; H Shabani S; Bolhassani A
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1227-1258. PubMed ID: 31583914
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracellular Delivery via Noncharged Sequence-Defined Cell-Penetrating Oligomers.
    Phan NN; Li C; Alabi CA
    Bioconjug Chem; 2018 Aug; 29(8):2628-2635. PubMed ID: 29953207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.